Back to My Search

Login is required to view Product Sheets and Certificates of Analysis.


Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-2678  Coxiella burnetii, Australia QD Phase II / RSA 425
(Bacteria)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Organism: Coxiella burnetii
Designations: Australia QD Phase II / RSA 425
Biosafety Level: 3
Availability Status: In Stock
Store at: -60°C or colder
Contributor: JE Samuel
Comments:
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

Coxiella burnetii (C. burnetii), strain Australia QD was isolated in Australia in ~ 1939 from the blood of a human with acute Q fever.

C. burnetii, strain Australia QD Phase II / RSA 425 is a genomic group I strain and contains plasmid QpH1. The phase character of the strain refers to reactivity with phase I or phase II hyperimmune serum.

Each vial contains 1 mL of bacteria in Bambanker™ Serum-Free Cell Freezing Medium. Bacteria were centrifuged from L929 mouse fibroblast cell lysate and resuspended in the freezing medium.
Citations: Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Coxiella burnetii, Strain Australia QD Phase II / RSA 425, NR-2678."
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
  • Select Agents require facility registration for specific agents with CDC and completion of APHIS/CDC Form 2. For information about toxin amounts excluded from CDC Select Agent regulations, click here.

Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search